- Home
- AEG vs ELAN Comparison
AEG vs ELAN Comparison
Compare AEG & ELAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | AEG | ELAN |
|---|---|---|
| Founded | 1983 | 1954 |
| Country | Netherlands | United States |
| Employees | 15304 | N/A |
| Industry | Life Insurance | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.1B | 12.7B |
| IPO Year | N/A | 2018 |
Fundamental Metrics
Financial Performance| Metric | AEG | ELAN |
|---|---|---|
| Price | $8.03 | $21.65 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 10 |
| Target Price | N/A | ★ $27.89 |
| AVG Volume (30 Days) | ★ 5.5M | 3.8M |
| Earning Date | 02-09-2023 | 05-06-2026 |
| Dividend Yield | ★ 4.68% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $4,715,000,000.00 |
| Revenue This Year | N/A | $8.21 |
| Revenue Next Year | N/A | $5.31 |
| P/E Ratio | $7.91 | ★ N/A |
| Revenue Growth | N/A | ★ 6.22 |
| 52 Week Low | $6.53 | $9.42 |
| 52 Week High | $8.20 | $27.72 |
Technical Indicators
Market Signals| Indicator | AEG | ELAN |
|---|---|---|
| Relative Strength Index (RSI) | 65.21 | 36.92 |
| Support Level | $7.50 | $20.73 |
| Resistance Level | $8.15 | $21.76 |
| Average True Range (ATR) | 0.10 | 0.79 |
| MACD | -0.01 | -0.12 |
| Stochastic Oscillator | 55.51 | 2.50 |
Price Performance
Historical ComparisonAbout AEG Aegon Ltd. New York Registry Shares
Aegon is a life insurance and long-term savings business listed in the Netherlands. It was listed on the Amsterdam Stock Exchange in the 1980s and now has mature operations in the United States, the United Kingdom, and four growth markets of Brazil, China, Portugal, and Spain. In recent years, Aegon has been moving through an extensive transformation program during which management has sought to divest noncore operations and improve the risk profile of the business. Financial assets are the parts of the company that are now being run off. Aegon is looking to cycle out of capital-consumptive and volatile earnings products and recycle capital into capital-light and more predictable strategic businesses.
About ELAN Elanco Animal Health Incorporated
Elanco Animal Health is an animal health company that is engaged in developing, manufacturing, and marketing pharma products for companion and food animals. It spun off from Eli Lilly in 2018 and acquired Janssen Animal Health in 2011, Novartis Animal Health in 2014, Boehringer Ingelheim Vetmedica in 2017, and Bayer Animal Health in 2020. The company's operations are conducted globally, and it sells its products in over 90 countries. It offers a range of food animal products used in cattle, sheep, goats, and swine production.